Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A question of balance.

Ramchandani P.

Nature. 2004 Jul 22;430(6998):401-2. No abstract available.

PMID:
15269742
2.

Antidepressants: bitter pills.

Check E.

Nature. 2004 Sep 9;431(7005):122-4. No abstract available.

PMID:
15356601
3.

Helping depressed children.

[No authors listed]

Nature. 2004 Sep 9;431(7005):111. No abstract available.

PMID:
15356589
4.

FDA questions antidepressant safety for children.

Oransky I.

Lancet. 2003 Nov 8;362(9395):1558. No abstract available.

PMID:
14627000
5.

The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

Brent DA.

Depress Anxiety. 2009;26(10):871-4. doi: 10.1002/da.20617. No abstract available.

6.

UK psychiatrists question SSRI warnings for under-18s.

Meek C.

CMAJ. 2004 Feb 17;170(4):455. No abstract available.

7.

Antidepressants and children. Buried data can be hazardous to a company's health.

Marshall E.

Science. 2004 Jun 11;304(5677):1576-7. No abstract available.

PMID:
15192185
8.

Spitzer sues drug giant for deceiving doctors.

Wadman M.

Nature. 2004 Jun 10;429(6992):589. No abstract available.

PMID:
15190317
9.

Calls for full disclosure of clinical trials.

Frantz S.

Nat Rev Drug Discov. 2004 Aug;3(8):635-6. No abstract available.

PMID:
15317144
10.

Drug company experts advised staff to withhold data about SSRI use in children.

Kondro W, Sibbald B.

CMAJ. 2004 Mar 2;170(5):783. No abstract available. Erratum in: CMAJ. 2004 Apr 13;170(8):1211.

12.

The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study.

Parabiaghi A, Franchi C, Tettamanti M, Barbato A, D'Avanzo B, Fortino I, Bortolotti A, Merlino L, Nobili A.

J Clin Psychopharmacol. 2012 Apr;32(2):303-5. doi: 10.1097/JCP.0b013e31824a076f. No abstract available.

PMID:
22388169
13.

Depressing misrepresentation?

Newton J, Langlands A.

Lancet. 2004 May 22;363(9422):1732. No abstract available.

PMID:
15158640
14.

Court filing makes public my previously suppressed analysis of Paxil's effects.

Breggin PR.

Ethical Hum Psychol Psychiatry. 2006 Spring;8(1):77-84. No abstract available.

PMID:
16862720
15.

Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?

Healy D.

Can J Psychiatry. 2009 Feb;54(2):69-71; discussion 76-7. No abstract available. Erratum in: Can J Psychiatry. 2009 May;54(5):350.

PMID:
19254434
16.

Antidepressants and suicide: a commentary on a significant contribution to this debate.

Goldney RD.

Crisis. 2005;26(2):97-8. No abstract available.

PMID:
16138748
17.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
18.

British drug company to put data online as criticism mounts.

Giles J.

Nature. 2004 Jun 24;429(6994):793. No abstract available.

PMID:
15215826
19.

TORDIA: unique opportunity to explore half-life theory.

Smith E.

Am J Psychiatry. 2009 Aug;166(8):936; author reply 936-7. doi: 10.1176/appi.ajp.2009.09050601. No abstract available.

PMID:
19651756
20.

Fluoxetine: new indication. Depression in children: too many uncertainties.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):186-7. No abstract available.

PMID:
19534039

Supplemental Content

Support Center